Science · Health
US drug regulator requires vision-loss warning on GLP-1 medicines
The FDA says manufacturers must warn of a potential risk of a rare eye condition that can cause permanent vision loss. An ophthalmology group says any increase in absolute risk appears small and causation has not been established.
